Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0232|93|1|36-42

ISSN： 0030-2414

Source： Oncology, Vol.93, Iss.1, 2017-04, pp. : 36-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 648-655

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy with Sequential Methotrexate and 5-Fluorouracil Scheduling, Epirubicin and Cisplatin for Locally Advanced Bladder Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 429-436

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Efficacy and Toxicity of Adjuvant Gemcitabine-Cisplatin Chemotherapy in Patients with Advanced Bladder Cancer Underwent Radical Cystectomy

By  

Current Urology, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and Radiation for Patients with Locally Advanced Bladder Cancer

By  

Urologia Internationalis, Vol. 67, Iss. 4, 2001-12 ,pp. : 293-297

Karger

Access to resources Recommend Favorite